6th National Harm Reduction Conference

Marriott Oakland City Center Hotel -- Oakland, CA
November 9 - 12, 2004

Injection Drug Users and Hepatitis C

Thursday, November 9, 2006 | 5:30 PM - 7:00 PM SIMMONS 1 (room) - Breakout Session 2

Presentations

Moderator

Donald Davis -- New York Harm Reduction Educators, NY, NY

Hepatitis C Group Work: The Power of Social Integration as a Learning and a Motivational Tool, Enhancing Entry Into Care

Andrea Lindstrom -- Lower East Side Harm Reduction Center, New York, NY

Hepatitis C Antibody Testing for Injection Drug Users: Problems and Prospects

Andrew Reynolds -- Haight Ashbury Free Mediccal Clinic, San Francisco, CA

Hepatitis C Treatment Among Community-Recruited Active Drug Users: Establishing a Collaborative, Multidisciplinary Model of Care PowerPoint presentation now available for download (236 Kb)

Michael Carden -- Center for the Study of Hep C, Cornell University, NY, NY

Ibogaine in the Treatment of Chronic Hepatitis C PowerPoint presentation now available for download (2.1 Mb)

Howard S. Lotsof -- President, Dora Weiner Foundation, Staten Island, NY

Ibogaine - History, Safety and access

Friday, November 10, 2006 | 5:45 PM - 7:15 PM SIMMONS 4 (room) - Breakout Session 7

Presentations

Moderator

Patrick Kroupa -- Chairman, MindVox, Inc.

History of the Science and Politics of ibogaine. PowerPoint presentation now available for download (2.8 Mb)

Howard S. Lotsof -- President, Dora Weiner Foundation, Staten Island, NY

Ibogaine Treatment Evolution

Patrtick K Kroupa -- Chairman, MindVox, Inc.

A Clinician's View of Ibogaine Detoxification

Jeffrey D. Kamlet, M.D. -- Board Certified Addictionologist. President Elect, Florida Society of Addiction Medicine (FSAM).

Ibogaine User Self-Help Groups

Dmitri Mugianis -- Positive Health Project, NY, NY

Immunological Activities of Ibogaine

Dana Beal -- Cures Not Wars, New York, NY

The Dora Weiner Foundation (DWF) will be supporting Howard Lotsof's ibogaine presentations during the 6th National Harm Reduction Coalition conferrence. DWF is a 501(c)3 not-for-profit corporation established in 1983. The activities of the Foundation are exclusively charitable, educational and scientific with the intent to encourage and promote public knowledge of research in the study of chemical dependence and substance-related disorders and to advocate for the rights of patients being treated for dependence to drugs. All donations to support the Foundation's work are tax deductable.

Checks or money orders should be written to the Dora Weiner Founation and addressed to:

Dora Weiner Foundation
46 Oxford Place
Staten Island, NY 10301
USA

For further information visit DWF's web page. Thank you for your support. We anticipate the conference presentations will result in saved lives. This solicitation is made solely on behalf of the Dora Weiner Foundation and not in affiliation with the Harm Reduction Coalition or any other organization.